Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.

A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for ...

A study of female U.S. service members found that getting a COVID-19 vaccine before or during pregnancy didn't raise the risk ...

A newly identified enzyme appears to control tau production, brain inflammation, and aging. Researchers at the University of ...

UCLA-led researchers identified a molecular switch that prevents lung blood vessel repair in bronchopulmonary dysplasia.

Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...

One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...

The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...